Akorn Inc fka AKRXQ

[KILLERMIKE]

Akorn Provides Fourth Quarter and Full Year 2019 Results
LAKE FOREST, Ill., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2019.

Fourth Quarter 2019 Results and Recent Developments

Net revenue was $162 million, an increase of $9 million, or 5.8%, compared to the fourth quarter of 2018.
Net loss was $81 million compared to a net loss of $215 million in the fourth quarter of 2018.
Adjusted EBITDA was $18 million compared to $(20) million in the fourth quarter of 2018.
Reached an agreement with our lenders to execute a sale of Akorn’s business, potentially using Chapter 11 protection, as previously disclosed on the Company’s Form 8-K filed on February 12, 2020.